In “6 Insights on PECAN” our PECAN expert Vincent Erdmann answers the most relevant questions of the PECAN process in France.
In “7 Insights on DiGA”, our DiGA expert Alexander Voigt provides answers to the most relevant questions about DiGA.
In an extensive article in PM-Report, Germany’s most significant pharma magazine, Digital Oxygen’s experts provide a 360° overview of DiGA in the context of pharma.
One aspect of DiGA is frequently left out in recent reports: The unknown number of DiGA prescriptions – the part of the DiGA iceberg that is not visible.
The DiGA Canvas is a comprehensive tool to assess the crucial questions, challenges, and requirements for your DiGA.
In this article, Torsten Christann comments on the importance, opportunities, and downsides of data for the pharma industry’s future business models.
There is a trend of DiGA start-ups looking for corporate partners and vice versa. But why?
Sensors, wearables, apps: Torsten Christann comments on the opportunities of self-measurement for the generation of Real-World-Evidence in Market Access processes.
In this article, Torsten Christann addresses the question whether pharma corporations should add DiGA to their portfolio or no.
At WIG2 Digital Health Conference, Healthcare Expert Alexander Voigt talked about what matters after the regulatory market access: Reaching patients.
